Matthias Dürst Selected Research

Matthias Dürst Research Topics

Disease

41	Neoplasms (Cancer) 06/2022 - 06/2002
18	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 04/2003
15	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 04/2011
14	Carcinoma (Carcinomatosis) 04/2022 - 06/2002
13	Ovarian Epithelial Carcinoma 01/2021 - 01/2011
10	Carcinogenesis 01/2018 - 12/2005
6	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 06/2012
5	Uterine Cervical Dysplasia 08/2013 - 06/2002
3	Breast Neoplasms (Breast Cancer) 03/2015 - 02/2004
2	Hypoxia (Hypoxemia) 12/2019 - 01/2017
2	Hypersensitivity (Allergy) 01/2015 - 05/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Obesity 01/2021
1	Endometriosis 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Genomic Instability 01/2016
1	Triple Negative Breast Neoplasms 01/2016
1	Residual Neoplasm 07/2013
1	Vulvar Neoplasms (Vulvar Cancer) 07/2013

Drug/Important Bio-Agent (IBA)

18	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2008
8	PlatinumIBA 06/2022 - 06/2013
7	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2002
6	Messenger RNA (mRNA)IBA 01/2021 - 05/2007
6	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 04/2003
5	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 06/2013
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2011
5	AntigensIBA 01/2019 - 04/2003
5	Biological ProductsIBA 01/2018 - 10/2004
4	Complementary DNA (cDNA)IBA 06/2011 - 10/2004
3	LigandsIBA 04/2022 - 11/2008
3	RNA (Ribonucleic Acid)IBA 10/2017 - 02/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 11/2011
2	ChromatinIBA 01/2021 - 09/2012
2	CarcinogensIBA 12/2019 - 12/2005
2	AntibodiesIBA 01/2019 - 12/2005
2	Transcription Factors (Transcription Factor)IBA 02/2017 - 01/2015
2	taxaneIBA 01/2016 - 06/2013
2	Pharmaceutical PreparationsIBA 06/2013 - 04/2007
2	Peptides (Polypeptides)IBA 11/2008 - 04/2003
2	Connexin 43 (Connexin43)IBA 04/2006 - 05/2005
2	Cancer VaccinesIBA 09/2003 - 09/2003
1	PalladiumIBA 06/2022
1	RutheniumIBA 04/2022
1	OsmiumIBA 04/2022
1	LipidsIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	CholesterolIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Ribonucleases (Ribonuclease)IBA 12/2020
1	micaIBA 11/2020
1	HLA-DQA1 antigen (HLA DQA1)IBA 11/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2020
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2019
1	ProteomeIBA 12/2019
1	Capsid Proteins (Capsid Protein)IBA 01/2019
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	Circulating Tumor DNAIBA 09/2017
1	Tumor Biomarkers (Tumor Markers)IBA 09/2017
1	Viral AntigensIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	cinnamic acidIBA 11/2016
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2016
1	Vitamin D FDA LinkGeneric 10/2016
1	25-hydroxyvitamin DIBA 10/2016
1	hydroxide ionIBA 10/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2016
1	Estrogens (Estrogen)FDA Link 10/2015
1	Hepatocyte Nuclear Factor 1IBA 03/2015
1	Hormones (Hormone)IBA 03/2015
1	GonadotropinsIBA 03/2015
1	Nonsense Codon (Nonsense Mutation)IBA 03/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2015
1	IronIBA 01/2015
1	Deoxyribonucleases (DNase)FDA Link 01/2015
1	histone H3 trimethyl Lys4IBA 01/2015
1	CarbonIBA 10/2014
1	purineIBA 10/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2014
1	pyrimidineIBA 10/2014
1	AgarIBA 08/2013
1	Cell Surface ReceptorsIBA 08/2013
1	TetraspaninsIBA 08/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2013
1	Crystallins (Crystallin)IBA 06/2013
1	Estrogen ReceptorsIBA 04/2013
1	Viral DNAIBA 01/2013
1	ORALIT (ORS)IBA 06/2012
1	Formaldehyde (Formol)FDA Link 02/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2011
1	Indicators and Reagents (Reagents)IBA 11/2011
1	BRCA1 ProteinIBA 11/2011

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 07/2009
5	Therapeutics 12/2019 - 07/2006
3	Immunotherapy 09/2003 - 04/2003
1	Lymph Node Excision (Lymph Node Dissection) 01/2021